Patient Guide: A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 10 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06663358
Status: 🟢 Enrolling Now
Condition: Fabry Disease
Phase: Not Specified

Where You Can Participate

This study is available at 10 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Atlanta, Georgia
  • • Chicago, Illinois
  • • And 7 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients - Join Clinical Trial NCTNCT06663358

How to Join This Clinical Trial - NCTNCT06663358

Learn how to participate in this Not Specified trial studying an investigational therapy for Fabry Disease. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Fabry Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Fabry Disease
Treatment Being Tested
Investigational treatment
Study Phase
Not Specified - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06663358 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 10 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35294 - United States

Status: RECRUITING

Clinical Research Site

Atlanta, Georgia 30322 - United States

Status: RECRUITING

Clinical Research Site

Chicago, Illinois 60611 - United States

Status: RECRUITING

Clinical Research Site

Iowa City, Iowa 52242 - United States

Status: RECRUITING

Clinical Research Site

Grand Rapids, Michigan 49525 - United States

Status: RECRUITING

Clinical Research Site

Fairfax, Virginia 22030 - United States

Status: RECRUITING

Clinical Research Site

Slovenj Gradec, 2380 - Slovenia

Status: RECRUITING

Clinical Research Site

Edgbaston, Birmingham B152TH - United Kingdom

Status: RECRUITING

Clinical Research Site

Salford, Greater Manchester M6 8HD - United Kingdom

Status: RECRUITING

Clinical Research Site

London, NW3 2QG - United Kingdom

Status: RECRUITING

How to Enroll in This Study

To learn more about participating in this Not Specified clinical trial for Fabry Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships